Screener
Bio-Rad Laboratories BIO Life Science — Goodwill, net
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Bio-Rad Laboratories in its filing.
Tagged under the XBRL concept us-gaap:Goodwill.
The source filing: Bio-Rad Laboratories’s 10-Q, filed April 30, 2026.
- Filed
- Apr 30, 2026, 4:19 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000012208-26-000035
| Balances as of December 31, 2025 | Life Science | Clinical Diagnostics | Total |
|---|---|---|---|
| Accumulated impairment losses | (41.8) | (293.4) | (335.2) |
| Goodwill, net | 451.4 | 128.4 | 579.8 |
| Foreign currency adjustments | (2.7) | — | (2.7) |
| Period change, net | (2.7) | — | (2.7) |
| Balances as of March 31, 2026 | |||
| Goodwill | 490.5 | 421.8 | 912.3 |
| Accumulated impairment losses | (41.8) | (293.4) | (335.2) |
| Goodwill, net | $448.7 | $128.4 | $577.1 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Bio-Rad Laboratories's life science — goodwill, net?
- Bio-Rad Laboratories (BIO) reported life science — goodwill, net of $448.7M in Q1 2026.
- How has Bio-Rad Laboratories's life science — goodwill, net changed year-over-year?
- Bio-Rad Laboratories's life science — goodwill, net increased by 53.9% year-over-year, from $291.5M to $448.7M.
- What is the long-term trend for Bio-Rad Laboratories's life science — goodwill, net?
- Over 4 years (2021 to 2025), Bio-Rad Laboratories's life science — goodwill, net has grown at a 13.3% compound annual growth rate (CAGR), from $999.8M to $1.65B.
- What does life science — goodwill, net mean?
- The net carrying value of goodwill for the Life Science segment after accounting for all historical impairment losses. It represents the remaining unamortized premium paid for acquisitions within this specific business unit.
Ask your AI about Bio-Rad Laboratories's life science — goodwill, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude